Institutional shares held 161 Million
1.97M calls
943K puts
Total value of holdings $736M
$9.02M calls
$4.32M puts
Market Cap $1.2B
257,338,000 Shares Out.
Institutional ownership 62.49%
# of Institutions 263


Latest Institutional Activity in MNKD

Top Purchases

Q1 2025
180 Wealth Advisors, LLC Shares Held: 2.19M ($10.2M)
Q1 2025
Sg Americas Securities, LLC Shares Held: 91.5K ($427K)
Q1 2025
Cambridge Investment Research Advisors, Inc. Shares Held: 49.3K ($230K)
Q1 2025
Palumbo Wealth Management LLC Shares Held: 97.5K ($455K)
Q1 2025
Rhumbline Advisers Shares Held: 399K ($1.86M)

Top Sells

Q1 2025
Hennion & Walsh Asset Management, Inc. Shares Held: 236K ($1.1M)
Q1 2025
Gamma Investing LLC Shares Held: 722 ($3.37K)
Q1 2025
International Assets Investment Management, LLC Shares Held: 10.8K ($50.4K)
Q1 2025
Fifth Third Bancorp Shares Held: 500 ($2.34K)
Q1 2025
Sequoia Financial Advisors, LLC Shares Held: 50.4K ($235K)

About MNKD

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.


Insider Transactions at MNKD

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
2.48M Shares
From 10 Insiders
Grant, award, or other acquisition 2.35M shares
Exercise of conversion of derivative security 135K shares
Sell / Disposition
1.4M Shares
From 13 Insiders
Payment of exercise price or tax liability 826K shares
Open market or private sale 453K shares
Bona fide gift 32.9K shares
Other acquisition or disposition 92.5K shares

Track Institutional and Insider Activities on MNKD

Follow MANNKIND CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MNKD shares.

Notify only if

Insider Trading

Get notified when an Mannkind Corp insider buys or sells MNKD shares.

Notify only if

News

Receive news related to MANNKIND CORP

Track Activities on MNKD